O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
Zhu H, Zhao T, Zhao S, Yang S, Jiang K, Li S, Kang Y, Yang Z, Shen J, Shen S, Tao H, Xuan J, Yang M, Xu B, Wang F, Jiang M.
Zhu H, et al. Among authors: jiang k.
Metabolism. 2024 Apr 18:155914. doi: 10.1016/j.metabol.2024.155914. Online ahead of print.
Metabolism. 2024.
PMID: 38642829